FDA recall D-0100-2017
Allergan Sales, LLC · Class II · drug
Product
TAZORAC (tazarotene) Gel 0.05%, Rx only, packaged in 15 x 3.5 g professional sample containers, Manufactured by: Allergan Inc., Irvine, CA 92512. UPC: 300238335159.
Reason for recall
Failed Content Uniformity Specifications
Distribution
Nationwide
Key facts
- Status
- Terminated
- Initiation date
- 2016-06-30
- Report date
- 2016-10-19
- Termination date
- 2017-12-06
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Waco, TX, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0100-2017